human NGO-Pr-54 protein
The antibody response against NGO-Pr-54 was observed in patients with bladder (5.1%), liver (4.1%), lung (3.4%), ovarian (5.6%), and prostate (4.2%) cancer, as well as with malignant melanoma (13.2%).
Also Known As:
NGO-Pr-54 protein, human
relevant articles (0 outcomes,
Bio-Agent Context: Research Results